Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. S. Gupta, L. M. Rodrigues, A. P. Esteves, A. M. F. Oliveira-Campos, M. São José Nascimento, N. Nazareh, H. Cidade, M. P. Neves, E. Fernandes, M. Pinto, N. M. F. S. A. Cerqueira, and N. Brás, Eur. J. Med. Chem., 43, 771 (2008).
2. Angermann, H. Franke, R. Preus, U. Hartfiel, H. Wagner, H. Bieringer, T. Auler, and C. Rosinger, DE Pat. Appl. 19751943; Chem. Abstr., 131, 5253t (1999).
3. J. L. Kelley, D. C. Wilson, V. L. Styles, F. E. Soroko, and B. R. Cooper, J. Heterocycl. Chem., 32, 1417 (1995).
4. A. El-Mekabaty, Synth. Commun., 44, 875 (2014).
5. M. Bakavoli, G. Bagherzadeh, M. Vaseghifar, A. Shiri, M. Pordel, M. Mashreghi, P. Pordeli, and M. Araghi, Eur. J. Med. Chem., 45, 647 (2010).
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Crystal structure determination and analyses of Hirshfeld surface, crystal voids, intermolecular interaction energies and energy frameworks of 1-benzyl-4-(methylsulfanyl)-3a,7a-dihydro-1H-pyrazolo[3,4-d]pyrimidine;Acta Crystallographica Section E Crystallographic Communications;2024-06-25
2. New pyrazolo[3,4-d]pyrimidine derivatives as EGFR-TK inhibitors: design, green synthesis, potential anti-proliferative activity and P-glycoprotein inhibition;RSC Advances;2024
3. Crystal structure determination, Hirshfeld surface, crystal void, intermolecular interaction energy analyses, as well as DFT and energy framework calculations of 2-(4-oxo-4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidin-1-yl)acetic acid;Acta Crystallographica Section E Crystallographic Communications;2022-08-31
4. Design, Synthesis, and Biological Evaluation of a Novel VEGFR-2 Inhibitor Based on a 1,2,5-Oxadiazole-2-Oxide Scaffold with MAPK Signaling Pathway Inhibition;Pharmaceuticals;2022-02-18
5. Pharmacological Significance of Triazoles and Tetrazoles in Neurodegenerative Disease: An Overview;N-Heterocycles;2022